Wednesday, 18 April 2007
ADDRESS INSERTED HERE
SALUTATION,
The included article is from a recent issue of Chemical & Engineering News (C&EN) published weekly by the American Chemical Society (ACS). The issue discussed within the article is, simply put, “the government [in its various reports] should separate drugs and chemicals”.
I believe the author, William Storck, makes a valid point in his thesis to count drug (pharmaceutical) data apart from chemical data.
When the reporting categories were originally created, I do think drugs could have been considered with the general chemical area. However, the pharmaceutical industry is completely changed from the earlier business models and the data should be reported in its own category.
The Louisiana Congressional Delegation should work together to get this change implemented within the various reporting areas affected.
Sincerely,
James R. Madden
Mailing List:
Senator Mary Landrieu
United States Senate
724 Hart Senate Office Building
Washington, DC 20510
Senator David Vitter
United States Senate
516 Hart Senate Office Building
Washington, DC 20510
Representative Bobby Jindal
United States House of Representatives
1205 Longworth House Office Building
Washington, DC 20515
Representative William Jefferson
United States House of Representatives
2113 Rayburn House Office Building
Washington, DC 20515
Representative Charlie Melancon
United States House of Representatives
404 Cannon House Office Building
Washington, DC 20515
Representative James O. McCrery
United States House of Representatives
2104 Rayburn House Office Building
Washington, DC 20515
Representative Rodney Alexander
United States House of Representatives
316 Cannon House Office Building
Washington, DC 20515
Representative Richard H. Baker
United States House of Representatives
341 Cannon House Office Building
Washington, DC 20515
Representative Charles W. Boustany, Jr.
United States House of Representatives
1117 Longworth House Office Building
Washington, DC 20515
No comments:
Post a Comment